280 likes | 418 Views
P-2. Leonard M. Baum, RPh. Vice President, Regulatory AffairsBayer HealthCareConsumer Care Division. P-3. Agenda. Regulatory Overview NaproxenADAPT TrialSafety EvaluationClinical PharmacologyClinical Studies Postmarketing SurveillanceObservational StudiesConclusions. P-4. Roche/Bayer Pr
E N D